Spineway (ALSPW) - Total Liabilities

Latest as of June 2025: €6.34 Million EUR ≈ $7.41 Million USD

Based on the latest financial reports, Spineway (ALSPW) has total liabilities worth €6.34 Million EUR (≈ $7.41 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash efficiency ratio of Spineway to assess how effectively this company generates cash.

Spineway - Total Liabilities Trend (2009–2024)

This chart illustrates how Spineway's total liabilities have evolved over time, based on quarterly financial data. Check ALSPW financial resilience to evaluate the company's liquid asset resilience ratio.

Spineway Competitors by Total Liabilities

The table below lists competitors of Spineway ranked by their total liabilities.

Company Country Total Liabilities
Sanginita Chemicals Limited
NSE:SANGINITA
India Rs468.23 Million
N1 Holdings Ltd
AU:N1H
Australia AU$166.62 Million
HeartCore Enterprises Inc
NASDAQ:HTCR
USA $9.51 Million
Dom Maklerski IDM SA
WAR:IDM
Poland zł1.73 Million
Spacetalk Ltd
AU:SPA
Australia AU$12.86 Million
Aquila SA
PA:ALAQU
France €5.99 Million
Nandani Creation Limited
NSE:JAIPURKURT
India Rs490.04 Million
Da Lue International Holding Co Ltd
TWO:4804
Taiwan NT$302.12 Million

Liability Composition Analysis (2009–2024)

This chart breaks down Spineway's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see ALSPW stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.34 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.27 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.21 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Spineway's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Spineway (2009–2024)

The table below shows the annual total liabilities of Spineway from 2009 to 2024.

Year Total Liabilities Change
2024-12-31 €6.17 Million
≈ $7.21 Million
-15.05%
2023-12-31 €7.26 Million
≈ $8.48 Million
+27.58%
2022-12-31 €5.69 Million
≈ $6.65 Million
+21.31%
2021-12-31 €4.69 Million
≈ $5.48 Million
-0.87%
2020-12-31 €4.73 Million
≈ $5.53 Million
-24.69%
2019-12-31 €6.28 Million
≈ $7.34 Million
-3.16%
2018-12-31 €6.49 Million
≈ $7.58 Million
-20.31%
2017-12-31 €8.14 Million
≈ $9.52 Million
-0.13%
2016-12-31 €8.15 Million
≈ $9.53 Million
+37.19%
2015-12-31 €5.94 Million
≈ $6.95 Million
-10.22%
2014-12-31 €6.62 Million
≈ $7.74 Million
+58.25%
2013-12-31 €4.18 Million
≈ $4.89 Million
+11.67%
2012-12-31 €3.74 Million
≈ $4.38 Million
+29.12%
2011-12-31 €2.90 Million
≈ $3.39 Million
+45.87%
2010-12-31 €1.99 Million
≈ $2.32 Million
+23.56%
2009-12-31 €1.61 Million
≈ $1.88 Million
--

About Spineway

PA:ALSPW France Medical Instruments & Supplies
Market Cap
$6.22 Million
€5.32 Million EUR
Market Cap Rank
#27934 Global
#506 in France
Share Price
€0.15
Change (1 day)
-0.13%
52-Week Range
€0.12 - €0.23
All Time High
€1000000.00
About

Spineway SA designs, develops, and markets a range of surgical implants for spine in France. The company offers posterior fixation, including posterior osteosynthesis systems and minimal invasive posterior osteosynthesis systems; interbody fusion products, such as lumbar cage twin peaks tlif curved and oblique; motion preservation products; and biomaterials. It also exports its products. The comp… Read more